Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Evaluation and Management of Hematuria

Initial Assessment and Risk Factors

  • A 54-year-old male with hypertension and positive blood on urinalysis without flank pain should be referred to urology for cystoscopy and imaging to rule out urinary tract malignancy, as his age and smoking history place him at higher risk for occult urinary tract cancer, according to the American College of Physicians 1, 2
  • The patient has several significant risk factors for urinary tract malignancy, including age over 40 years, as stated by the American College of Physicians 1, 2
  • Male gender is a significant risk factor for urinary tract malignancy, as reported by the American College of Physicians 3

Diagnostic Approach

  • First, confirm the hematuria with microscopic urinalysis showing ≥3 red blood cells per high-powered field, as recommended by the American College of Physicians 4
  • This is essential as dipstick tests can have false-positive results in up to one-third of cases, according to the American College of Physicians 3
  • Ask about any history of gross hematuria (visible blood in urine), which carries a higher risk of malignancy (30-40%), as stated by the American College of Radiology 5
  • Determine if there are any benign causes of hematuria, such as urinary tract infection, recent vigorous exercise, trauma, or recent urologic procedures, as reported by the American College of Radiology 5 and the American College of Physicians 4

Referral Decision

  • For this patient, urology referral is indicated based on age ≥40 years with microscopically confirmed hematuria, as recommended by the American College of Physicians 1, 2
  • Absence of an obvious benign cause is also an indication for urology referral, according to the American College of Physicians 6
  • Women have substantially lower rates of urology referral (8-28% vs 36-47% for men), as reported by the American College of Physicians 3
  • Delays in referral >9 months are associated with worse cancer-specific survival, according to the American College of Physicians 3
  • The urologic evaluation should include cystoscopy to directly visualize the bladder, as recommended by the American College of Physicians 6
  • Upper tract imaging (CT urography is preferred), as stated by the American College of Radiology 5
  • Urine cytology is NOT recommended in the initial evaluation, as reported by the American College of Physicians 1, 4
  • This evaluation should be pursued even if the patient is on antiplatelet or anticoagulant therapy, according to the American College of Radiology 7

Common Pitfalls to Avoid

  • Do not attribute hematuria solely to hypertension without proper urologic evaluation, as recommended by the American College of Physicians 3
  • Do not delay referral due to absence of symptoms, as urinary tract cancers can be asymptomatic in early stages, according to the American College of Physicians 2
  • Do not rely on dipstick testing alone; microscopic confirmation is essential, as reported by the American College of Physicians 4
  • Do not obtain urinary cytology or other urine-based molecular markers for bladder cancer detection in the initial evaluation, as stated by the American College of Physicians 3